Rare bone tumor under the microscope: can we predict its behavior?

NCT ID NCT07360964

Ongoing Knowledge-focused Sponsor: Istituto Ortopedico Rizzoli Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study gathers information from 77 Italian patients with a rare, low-grade bone tumor called clear cell chondrosarcoma. Researchers will review medical records, imaging, and tissue samples to find patterns that might predict whether the tumor will come back or spread. The goal is to create a model that helps doctors better estimate a patient's outlook, but no new treatments are being tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could provide doctors with better tools to predict how this rare bone tumor will behave, helping guide treatment decisions.
What could go wrong: This is an observational study, not a treatment trial. It looks back at past cases, so results may not apply to future patients. The small number of cases (77) limits how much we can learn.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHONDROSARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chondrosarcoma Chondrosarcoma, Clear Cell clear cell chondrosarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHONDROSARCOMA

Contacts and locations

Locations

IRCC Rizzoli Orthopedic Institute

Bologna, 40136, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.